3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Clinical trial NCT00064051 · COMPLETED
Trial details
- NCT number
- NCT00064051
- Sponsor
- Vion Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Primary completion
- 2006-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.